← Back to Search

Behavioural Intervention

Health Literacy Intervention for Pap Smear Follow-Up (PALS Trial)

N/A
Waitlist Available
Led By Eloise Chapman-Davis, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All Women 21-65 years with diagnosis of abnormal pap smear presenting to Women's Health Colposcopy Clinic at WCMC
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3-4
Awards & highlights

PALS Trial Summary

This trial will use patient interviews to design an intervention to increase knowledge of cervical cancer screening and treatment, and reduce barriers to appropriate follow-up.

Who is the study for?
This trial is for women aged 21-65 with an abnormal pap smear who are visiting the Women's Health Colposcopy Clinic at WCMC. Participants must have access to a smartphone and speak either English or Spanish. Pregnant women and non-English or Spanish speakers cannot participate.Check my eligibility
What is being tested?
The study is testing 'PALS', an intervention developed from patient interviews, aimed at improving understanding of cervical cancer screening and addressing barriers to follow-up care after an abnormal pap smear result.See study design
What are the potential side effects?
Since 'PALS' is an informational intervention rather than a medical treatment, traditional physical side effects are not applicable. However, participants may experience emotional or psychological responses to the content.

PALS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 21-65 with an abnormal pap smear result.

PALS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3-4
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3-4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Knowledge change
Reusable knowledge objects (RKOs)

PALS Trial Design

1Treatment groups
Experimental Treatment
Group I: PALS interventionExperimental Treatment1 Intervention
This arm will influence the development of a patient-directed education module using the Patient Activated Learning System (PALS)

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,059 Previous Clinical Trials
1,316,083 Total Patients Enrolled
Eloise Chapman-Davis, MDPrincipal InvestigatorWeill Medical College of Cornell University
~3 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top